000 02268nam a22003617a 4500
008 240424s20242024 xxu||||| |||| 00| 0 eng d
022 _a1878-8750
024 _aS1878-8750(24)00239-0 [pii]
040 _aOvid MEDLINE(R)
099 _a38364898
245 _aPatient-Reported Outcomes for Spine Oncology: A Narrative Review. [Review]
251 _aWorld Neurosurgery. 185:165-170, 2024 Feb 15.
252 _aWorld Neurosurg. 185:165-170, 2024 Feb 15.
253 _aWorld neurosurgery
260 _c2024
260 _fFY2024
260 _p2024 Feb 15
265 _saheadofprint
265 _tPublisher
266 _d2024-04-24
520 _aSpine tumors, both primary and metastatic, impose significant morbidity and mortality on patients and physicians. Patient-reported outcomes are valuable tools to assess a patient's impression of their health status and enhance communication between physicians and patients. Various spine generic patient-reported outcome tools have traditionally been used but have not been validated in the spine tumor patient population. The Spine Oncology Study Group Outcome Questionnaire, which is disease-specific for the metastatic spine patient population, has been shown to have strong validity, even across multiple languages. Patient-Reported Outcomes Measurement Information System, which has recently been developed, employs computerized adaptive testing to assess multiple health domains. It has been shown to capture information in both generic and specific questionnaires and has the potential to be used as a universal tool in the spine oncology patient population. Further long-term studies, as well as, cross-cultural adaptations, are needed to validate Patient-Reported Outcomes Measurement Information System's applicability and effectiveness. Copyright Published by Elsevier Inc.
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
650 _zAutomated
651 _aMedStar Washington Hospital Center
656 _aOrthopedic Surgery
657 _aJournal Article
657 _aReview
700 _aMesfin, Addisu
_bMWHC
790 _aSaha P, Cady-McCrea C, Puvanesarajah V, Mesfin A
856 _uhttps://dx.doi.org/10.1016/j.wneu.2024.02.042
942 _cART
_dArticle
999 _c14085
_d14085